Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Protalix BioTherapeutics Q2 EPS $(0.25) Down From $(0.13) YoY

Protalix BioTherapeutics (AMEX:PLX) reported quarterly losses of $(0.25) per share. This is a 92.31 percent decrease over losses of $(0.13) per share from the same period last year.
byBenzinga Newsdesk
August 16, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Protalix BioTherapeutics (AMEX:PLX) reported quarterly losses of $(0.25) per share. This is a 92.31 percent decrease over losses of $(0.13) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Preview: Heritage Global

By Benzinga Insights
Today, 11:49 AM
Heritage Global (NASDAQ:HGBL) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts estimate that Heritage Global will report an earnings per share (EPS) of $0.05.

HGBL